We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
-10.85%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$9.04B
AUM Growth
-$1.43B
Cap. Flow
-$151M
Cap. Flow %
-1.67%
Top 10 Hldgs %
18.65%
Holding
2,374
New
143
Increased
1,021
Reduced
923
Closed
229

Sector Composition

Rank Sector Weight
1 Technology 5.77%
2 Financials 4.93%
3 Healthcare 4.61%
4 Consumer Discretionary 3.54%
5 Industrials 3.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RMTI icon
2101
Rockwell Medical
RMTI
$27.9M
$27K ﹤0.01%
+107
New +$42.6K
PLUG icon
2102
Plug Power
PLUG
$3.1B
$26K ﹤0.01%
20,771
-55
-0.3% -$93
ATHX
2103
DELISTED
Athersys, Inc. Common Stock
ATHX
$26K ﹤0.01%
722
+210
+41% +$10K
CLNE icon
2104
Clean Energy Fuels
CLNE
$377M
$25K ﹤0.01%
14,590
-1,690
-10% -$3.74K
NBR icon
2105
Nabors Industries
NBR
$1.3B
$25K ﹤0.01%
+247
New +$54.4K
ADMA icon
2106
ADMA Biologics
ADMA
$2.22B
$24K ﹤0.01%
+10,000
New +$49.5K
DNR
2107
DELISTED
Denbury Resources, Inc.
DNR
$24K ﹤0.01%
+13,745
New +$47.3K
TURN
2108
DELISTED
180 Degree Capital
TURN
$23K ﹤0.01%
4,355
+47
+1% +$284
SDR
2109
DELISTED
SANDRIDGE MISSISSIPPIAN TRUST II
SDR
$23K ﹤0.01%
26,734
+884
+3% +$963
EXK
2110
Endeavour Silver
EXK
$3.14B
$22K ﹤0.01%
+10,010
New +$21K
VIVS
2111
VivoSim Labs
VIVS
$1.23M
$22K ﹤0.01%
98
-11
-10% -$2.77K
UQM
2112
DELISTED
UQM Technologies, Inc.
UQM
$22K ﹤0.01%
25,869
GERN icon
2113
Geron
GERN
$1.05B
$20K ﹤0.01%
19,645
-5,974
-23% -$9.07K
OBE
2114
Obsidian Energy
OBE
$710M
$19K ﹤0.01%
6,797
-228
-3% -$1.01K
IDXG
2115
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$18K ﹤0.01%
2,260
-1
-0% -$12
SDLP
2116
DELISTED
SEADRILL PARTNERS LLC
SDLP
$18K ﹤0.01%
1,065
LUMO
2117
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$17K ﹤0.01%
1,213
-596
-33% -$10.5K
ALIM
2118
DELISTED
Alimera Sciences
ALIM
$17K ﹤0.01%
1,587
AXAS
2119
DELISTED
Abraxas Petroleum Corp
AXAS
$16K ﹤0.01%
750
-416
-36% -$14.5K
UPL
2120
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
$16K ﹤0.01%
21,512
+8,640
+67% +$10.9K
TGB
2121
Trekor Metals
TGB
$3.23B
$15K ﹤0.01%
31,350
WPRT
2122
Westport Fuel Systems
WPRT
$36.7M
$15K ﹤0.01%
1,134
-99
-8% -$2.24K
FCSC
2123
DELISTED
Fibrocell Science Inc.
FCSC
$15K ﹤0.01%
10,016
-69
-0.7% -$138
KONA
2124
DELISTED
Kona Grill, Inc.
KONA
$14K ﹤0.01%
+13,500
New +$24.2K
NAVB
2125
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$12K ﹤0.01%
5,937
+32
+0.5% +$132

Similar funds

Cambridge Investment Research Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, Cambridge Investment Research Advisors held 2,374 positions worth $9.04B, down 14% from $10.5B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Cambridge Investment Research Advisors's Q4 2018 filing shows 143 new, 1,021 increased, 923 reduced and 229 closed positions. Its largest new stake was PIMCO Enhanced Low Duration Active Exchange-Traded Fund: 78,644 shares worth $7.77M. The largest sale was Invesco QQQ Trust, an estimated $32.9M.

By sector, the portfolio is most concentrated in Technology at 5.8% of assets, down from 6.6% a quarter earlier, followed by Financials and Healthcare.

  • Cambridge Investment Research Advisors's largest Q4 2018 buy was PIMCO Enhanced Low Duration Active Exchange-Traded Fund: 78,644 shares worth $7.77M.
  • Cambridge Investment Research Advisors added most to Vanguard Short-Term Treasury ETF in Q4 2018, an estimated $58M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2018 reduction was Invesco QQQ Trust, cutting an estimated $32.9M.
  • Cambridge Investment Research Advisors fully exited iShares US Oil & Gas Exploration & Production ETF in Q4 2018, selling an estimated $17M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 19% of its $9.04B portfolio in Q4 2018.
  • Cambridge Investment Research Advisors opened 143 new positions and closed 229 in Q4 2018.
  • Cambridge Investment Research Advisors's portfolio value fell 14% quarter-over-quarter to $9.04B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2018, filed 5 Feb 2019.